Ko-Jen Li, Chia-Li Chang, Chih-Yi Hsin, & Chao-Hsiun Tang. (2021). Switching and Discontinuation Pattern of Biologic Disease-Modifying Antirheumatic Drugs and Tofacitinib for Patients With Rheumatoid Arthritis in Taiwan. Frontiers Media S.A..
Chicago Style (17th ed.) CitationKo-Jen Li, Chia-Li Chang, Chih-Yi Hsin, and Chao-Hsiun Tang. Switching and Discontinuation Pattern of Biologic Disease-Modifying Antirheumatic Drugs and Tofacitinib for Patients With Rheumatoid Arthritis in Taiwan. Frontiers Media S.A., 2021.
MLA (9th ed.) CitationKo-Jen Li, et al. Switching and Discontinuation Pattern of Biologic Disease-Modifying Antirheumatic Drugs and Tofacitinib for Patients With Rheumatoid Arthritis in Taiwan. Frontiers Media S.A., 2021.
Warning: These citations may not always be 100% accurate.